{content}

Study list

Harrall

United Kingdom
|
2021-2025
  • Adults
  • General population
  • Elderly
  • Community
  • SARS-CoV-2
  • Post-COVID-19

UKILD-Long COVID

United Kingdom
|
2021-2024
  • Adults
  • General population
  • Elderly
  • Community
  • SARS-CoV-2
  • Post-COVID-19

Yildiz

Türkiye
|
2021-2023
  • Adults
  • General population
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

PL-PC19

Italy
|
2021-2022
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Dietary
  • Lifestyle

COCOPREV

France
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Dierckx

Belgium
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Vicente-Valor

Spain
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

LC-cohort

Finland
|
2021-2024
  • Adults
  • Elderly
  • Paediatric
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

LCV

Italy
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Community
  • SARS-CoV-2
  • Post-COVID-19

Huygens

The Netherlands
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

POSTCODE

United Kingdom
|
2021-2024
  • Adults
  • General population
  • Elderly
  • Paediatric
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Azevedo

Portugal
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19